ATG4D and invasive ductal breast carcinoma: Notably, anomalies in ATG4D promoter methylation and its defective expression have been correlated with a suppression of the autophagy signaling pathway, as evidenced in invasive ductal carcinoma and human uterine fibroids [38, 39].